The technological advances that led to the advent of target-based drug discovery in the 1990s enabled researchers to chemically target specific genes and molecules, thus allowing for the development of drugs that can be more precisely delivered. The drawback to this approach lies in the often time-consuming “hit-and-miss” process of matching the right drug with […]

The University of Missouri-Kansas City (UMKC) School of Medicine and Research Medical Center (RMC) have signed an affiliation agreement to develop and provide joint undergraduate, post-graduate and fellowship medical training programs. The agreement will also allow the two institutions to cooperate in promoting and enhancing faculty development, education and biomedical research.